{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:45:10Z","timestamp":1775609110054,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1991,9,1]],"date-time":"1991-09-01T00:00:00Z","timestamp":683683200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1991,9]]},"DOI":"10.1007\/bf00315434","type":"journal-article","created":{"date-parts":[[2004,10,12]],"date-time":"2004-10-12T10:35:12Z","timestamp":1097577312000},"page":"225-231","source":"Crossref","is-referenced-by-count":8,"title":["RU 41 656 does not reverse the scopolamine-induced cognitive deficit in healthy volunteers"],"prefix":"10.1007","volume":"41","author":[{"given":"A.","family":"Patat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Surjus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hucher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Granier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0163-1047(86)90772-7","volume":"45","author":"WW Beatty","year":"1986","unstructured":"Beatty WW, Butters N, Janowsky DS (1986) Patterns of memory failure after scopolamine treatment: implication for cholinergic hypothesis of dementia. Behav Neurol Biol 45: 196?211","journal-title":"Behav Neurol Biol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0753-3322(89)90109-1","volume":"43","author":"F Boller","year":"1989","unstructured":"Boller F, Forette F (1989) Alzheimer's disease and THA: a review of cholinergic theory and preliminarey results. Biomed Pharmacother 43: 487?491","journal-title":"Biomed Pharmacother"},{"key":"CR3","first-page":"523","volume":"12","author":"A Bond","year":"1974","unstructured":"Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 12: 523?533","journal-title":"Br J Med Psychol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0028-3932(88)90004-8","volume":"26","author":"P Broks","year":"1988","unstructured":"Broks P, Preston GC, Traub M, Poppleton P, Ward C, Stahl SM (1988) Modelling dementia: effects of scopolamine on memory and attention. Neuropsychologia 26: 685?700","journal-title":"Neuropsychologia"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0022-5371(73)80034-9","volume":"12","author":"H Buschke","year":"1973","unstructured":"Buschke H (1973) Selective reminding for analysis of memory and learning. J Verb Learn Behav 12: 543?550","journal-title":"J Verb Learn Behav"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1212\/WNL.24.11.1019","volume":"24","author":"H Buschke","year":"1974","unstructured":"Buschke H, Fuld PA (1974) Evaluation storage, retention and retrieval in disordered memory and learning. Neurology 24: 1019?1024","journal-title":"Neurology"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/BF00431761","volume":"74","author":"ED Caine","year":"1981","unstructured":"Caine ED, Weingartner H, Ludlow CL, Cudahy EA, Wehry S (1981) Qualitative analysis of scopolamine-induced amnesia. Psychopharmacol 74: 74?80","journal-title":"Psychopharmacol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF00428401","volume":"85","author":"E Callaway","year":"1985","unstructured":"Callaway E, Halliday R, Naylor H, Schechter G (1985) Effects of oral scopolamine on human stimulus evaluation. Psychopharmacol 85: 133?138","journal-title":"Psychopharmacol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2125.1975.tb02789.x","volume":"2","author":"TJ Crow","year":"1975","unstructured":"Crow TJ, Grove-White IG, Ross DG (1975) The specificity of the action of hyoscine on human learning. Br J Clin Pharmacol 2: 367?368","journal-title":"Br J Clin Pharmacol"},{"key":"CR10","first-page":"53","volume-title":"Stategies for the development of an effective treatment for senile dementia","author":"KL Davis","year":"1981","unstructured":"Davis KL, Mohs RC, Davis BM, Levy M, Rosenberg GS, Horvath TB, De Nigris Y, Ross A, Decker P, Rothpearl A (1981) Cholinomimetic agents and human memory: clinical studies in Alzheimer's disease and scopolamine dementia. In Crook T, Gershon S (eds) Stategies for the development of an effective treatment for senile dementia. Mark Powley, New Canaan, pp 53?59"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archneur.1974.00490320001001","volume":"30","author":"DA Drachman","year":"1974","unstructured":"Drachman DA, Leavitt J (1974) Human memory and the cholinergic system. Arch Neurol 30: 113?121","journal-title":"Arch Neurol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1212\/WNL.27.8.783","volume":"27","author":"DA Drachman","year":"1977","unstructured":"Drachman DA (1977) Memory and cognitive function in man: does the cholinergic system have a specific role? Neurology 27: 783?790","journal-title":"Neurology"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/BF00558250","volume":"35","author":"J Drewe","year":"1988","unstructured":"Drewe J, Mazer N, Abisch E, Krummen K, Keck M (1988) Differential effect of food on kinetics of bromocriptine in a modified release capsule and a conventionnal formulation. Eur J Clin Pharmacol 35: 535?541","journal-title":"Eur J Clin Pharmacol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0001-6918(85)90020-4","volume":"58","author":"MP Dunne","year":"1985","unstructured":"Dunne MP, Hartley IR (1985) The effects of scopolamine upon verbal memory: evidence for an attentional hypothesis. Acta Psychol 58: 205?217","journal-title":"Acta Psychol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/BF00175197","volume":"89","author":"MP Dunne","year":"1986","unstructured":"Dunne MP, Hartley IR (1986) Scopolamine and the control of attention in humans. Psychopharmacol 89: 94?97","journal-title":"Psychopharmacol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF02244414","volume":"100","author":"C Flicker","year":"1990","unstructured":"Flicker C, Serby M, Ferris SH (1990) Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed. Psychopharmacol 100: 243?250","journal-title":"Psychopharmacol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0163-1047(86)90750-8","volume":"45","author":"JF Flood","year":"1986","unstructured":"Flood JF, Cherkin A (1986) Scopolamine effects on memory retention in mice: a model of dementia. Behav Neur Biol 45: 169?184","journal-title":"Behav Neur Biol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/14640748408401507","volume":"36","author":"LD Frith","year":"1984","unstructured":"Frith LD, Richardson JTE, Samuel M, Crow TS, McKenna PJ (1984) The effects of intravenous diazepam and hyoscine upon human memory. Q J Exp Psychol 36A; 133?144","journal-title":"Q J Exp Psychol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ana.410110208","volume":"11","author":"PA Fuld","year":"1982","unstructured":"Fuld PA, Katzman R, Davies P, Terry RD (1982) Intrusions as a sign of Alzheimer dementia: chemical and pathological verification. Ann Neurol 11: 155?159","journal-title":"Ann Neurol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF00428903","volume":"44","author":"MM Ghoneim","year":"1975","unstructured":"Ghoneim MM, Mewaldt SP (1975) Effects of diazepam and scopolamine on storage, retrieval and organisational processes in memory. Psychopharmacol (Berl) 44: 257?262","journal-title":"Psychopharmacol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00426592","volume":"52","author":"MM Ghoneim","year":"1977","unstructured":"Ghoneim MM, Mewaldt SP (1977) Studies on human memory: the interactions of diazepam, scopolamine and physostigmine. Psychopharmacol 52: 1?6","journal-title":"Psychopharmacol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1212\/WNL.37.2.346","volume":"37","author":"EJ Hammond","year":"1987","unstructured":"Hammond EJ, Meador KJ, Aung Din R, Wilder BS (1987) Cholinergic modulation of human P 300 event related potentials. Neurology 37: 346?350","journal-title":"Neurology"},{"key":"CR23","first-page":"67","volume":"36","author":"KY Ho","year":"1988","unstructured":"Ho KY, Thorner MO (1988) Therapeutic applications of bromocriptine in endocrine and neurological diseases. Drugs 36: 67?82","journal-title":"Drugs"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0028-3932(85)90064-8","volume":"23","author":"MD Kopelman","year":"1985","unstructured":"Kopelman MD (1985) Rates of forgetting in Alzheimer-type dementia and Korsakoff's syndrome. Neuropsychol 23: 623?638","journal-title":"Neuropsychol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/14640748608401614","volume":"38","author":"MD Kopelman","year":"1986","unstructured":"Kopelman MD (1986) The cholinergic neurotransmitter system in human memory and dementia. Q J Exp Psychol 38A: 535?574","journal-title":"Q J Exp Psychol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/brain\/111.5.1079","volume":"111","author":"MD Kopelman","year":"1988","unstructured":"Kopelman MD, Corn T (1988) Cholinergic blockage as a model for cholinergic depletion. Brain 111: 1079?1110","journal-title":"Brain"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1037\/10057-035","volume-title":"Handbook for clinical memory assessment in older adults","author":"RC Mohs","year":"1986","unstructured":"Mohs RC, John CA, Dunn DD, Sherman NA, Rosen WG, Davis KL (1986) Anticholinergic dementia as a model of Alzheimer' disease. In Poon LW (ed) Handbook for clinical memory assessment in older adults. American Psychological Association, Washington (DC) pp 403?408"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/14640748608401615","volume":"38","author":"RG Morris","year":"1986","unstructured":"Morris RG, Kopelman MD (1986) The memory deficits in Alzheimer-type dementia: a review. Q J Exp Psychol 38A: 575?602","journal-title":"Q J Exp Psychol"},{"key":"CR29","first-page":"347","volume":"89","author":"AC Parrot","year":"1986","unstructured":"Parrot AC (1986) The effects of transdermal scopolamine and four dose levels of oral scopolamine (0.15, 0.30, 0.6 and 1.2 mg) upon psychological performance. Psychopharmacol 89: 347?354","journal-title":"Psychopharmacol"},{"key":"CR30","first-page":"513","volume":"92","author":"AC Parrot","year":"1987","unstructured":"Parrot AC, Wesnes K (1987) Promethazine, scopolamine and cinnarizine: comparative time course of psychological performance effects. Psychopharmacol 92: 513?519","journal-title":"Psychopharmacol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/hup.470050405","volume":"5","author":"A Patat","year":"1990","unstructured":"Patat A, Klein MJ, Surjus A, Hucher M, Granier J (1990) Study of the potential pharmacodynamic antagonism of RU 41 656 on scopolamine and triazolam impairment in healthy subjects. Hum Psychopharmacol 5: 323?337","journal-title":"Hum Psychopharmacol"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/h0025327","volume":"76","author":"A Pavio","year":"1968","unstructured":"Pavio A, Yuille JC, Madigan SA (1968) Concreteness, imagery and meaningfulness values for 925 nouns. J Exp Psychol 76: 1?25","journal-title":"J Exp Psychol"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1136\/bmj.2.6150.1457","volume":"2","author":"EK Perry","year":"1978","unstructured":"Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 2: 1457?1459","journal-title":"Br Med J"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF00426713","volume":"52","author":"RC Peterson","year":"1977","unstructured":"Peterson RC (1977) Scopolamine-induced learning failures in man. Psychopharmacol 52: 283?289","journal-title":"Psychopharmacol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/026988118800200202","volume":"2","author":"GC Preston","year":"1988","unstructured":"Preston GC, Brazell C, Ward C, Broks P, Traub M, Stahl SM (1988) The scopolamine model of dementia: determination of central cholinomimetic effects of physostigmine on cognition and biochemical markers in man. J Psychopharmacol 2: 67?79","journal-title":"J Psychopharmacol"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/BF00441947","volume":"98","author":"GC Preston","year":"1989","unstructured":"Preston GC, Ward C, Lines CR, Poppleton P, Haigh JRM, Traub M (1989) Scopolamine and benzodiazepine models of dementia: cross-reversals by Ro15-1788 and physostigmine. Psychopharmacol 98: 487?494","journal-title":"Psychopharmacol"},{"key":"CR37","first-page":"145","volume":"96","author":"JM Rusted","year":"1988","unstructured":"Rusted JM, Warburton DM (1988) The effects of scopolamine on working memory in healthy young volunteers. Psychopharmacol 96: 145?152","journal-title":"Psychopharmacol"},{"key":"CR38","first-page":"347","volume":"3","author":"DJ Safer","year":"1971","unstructured":"Safer DJ, Allen RP (1971) The central effects of scopolamine in man. Biol Psychiat 3: 347?355","journal-title":"Biol Psychiat"},{"key":"CR39","first-page":"393","volume-title":"Handbook of Psychopharmacol 20","author":"BJ Sahakian","year":"1987","unstructured":"Sahakian BJ (1987) Cholinergic drugs and human cognitive performance in Iversen L, Iversen SD, Snyder SH (eds). Handbook of Psychopharmacol 20, Plenum Press, New York, pp 393?424"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000118365","volume":"17","author":"WG Sannita","year":"1987","unstructured":"Sannita WG, Maggi L, Rosadini G (1987) Effects of scopolamine (0.25?0.50 mg IM) on the quantitative EEG and the neuropsychological status of healthy volunteers. Neuropsychobiol 17: 199?205","journal-title":"Neuropsychobiol"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/BF02247137","volume":"102","author":"AT Smith","year":"1990","unstructured":"Smith AT, Early F, Jones GH (1990) Comparison of the effects of Alzheimer's disease, normal aging and scopolamine on human transient visual evoked potentials. Psychopharmacol 102: 535?543","journal-title":"Psychopharmacol"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0278-5846(86)90030-8","volume":"10","author":"T Sunderland","year":"1986","unstructured":"Sunderland T, Tariot P, Weingartner H, Murphy D, Newhouse P, Mueller E, Cohen R (1986) Pharmacological modelling of Alzheimer's disease. Prog. Neuropsychopharmacol Biol Psychiat 10: 599?610","journal-title":"Prog. Neuropsychopharmacol Biol Psychiat"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1749-6632.1985.tb37601.x","volume":"444","author":"M Weingartner","year":"1985","unstructured":"Weingartner M (1985) Models of memory dysfunction. Ann N Y Acad Sci 444: 359?369","journal-title":"Ann N Y Acad Sci"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000117954","volume":"9","author":"K Wesnes","year":"1983","unstructured":"Wesnes K, Warburton D (1983) Effects of scopolamine and nicotine on stimulus sensitivity and response bias in a visual vigilance task. Neuropsychobiol 9: 154?157","journal-title":"Neuropsychobiol"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00427761","volume":"82","author":"K Wesnes","year":"1984","unstructured":"Wesnes K, Warburton D (1984) Effects of scopolamine and nicotine on human rapid information processing performance. Psychopharmacol 82: 147?150","journal-title":"Psychopharmacol"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00432014","volume":"84","author":"K Wesnes","year":"1984","unstructured":"Wesnes K, Revell A (1984) The separate and combined effects of scopolamine and nicotine on human information processing. Psychopharmacol 84: 5?11","journal-title":"Psychopharmacol"},{"key":"CR47","first-page":"1063","volume":"15","author":"K Wesnes","year":"1987","unstructured":"Wesnes K, Simpson P, Kidd A (1987) The use of scopolamine to study the nootropic effects of CAS 997 in man. Med Sci Res 15: 1063?1064","journal-title":"Med Sci Res"},{"key":"CR48","first-page":"236","volume-title":"In practical aspects of memory: current research and issues, vol 2","author":"K Wesnes","year":"1988","unstructured":"Wesnes K, Simpson P (1988) Can scopolamine produce a model of the memory deficits seen in aging and dementia. In practical aspects of memory: current research and issues, vol 2, MM Gruneberg, PE Morris, RN Sykes (eds). Wiley, New York, pp 236?241"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hup.470030106","volume":"3","author":"K Wesnes","year":"1988","unstructured":"Wesnes K, Simpson P, Kidd A (1988) An investigation of the range of cognitive impairments induced by scopolamine 0.6 mg S.C. Human Psychopharmacol 3: 27?41","journal-title":"Human Psychopharmacol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00315434.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00315434\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00315434","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T15:08:52Z","timestamp":1554304132000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00315434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,9]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1991,9]]}},"alternative-id":["BF00315434"],"URL":"https:\/\/doi.org\/10.1007\/bf00315434","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,9]]}}}